INFUSYSTEM HOLDINGS, INC Weighted Average Number of Shares Outstanding, Basic and Diluted
INFUSYSTEM HOLDINGS, INC (INFU) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 19.92 million shares for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-05-15
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 19.92M shares, a 1.73% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 19.58M shares.
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-12-31 was 19.54M shares, a 14.22% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 20.67M shares, a 9.15% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 21.42M shares, a 5.81% decline from fiscal 2017.
- INFUSYSTEM HOLDINGS, INC weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 22.74M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-03-31 | 19.92M shares 10-Q · filed 2020-05-15 | |||
| 2019-03-31 | 19.58M shares 10-Q · filed 2020-05-15 | 19.56M shares derived: average of 2 quarters · filed 2020-05-15 | 19.93M shares derived: average of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | 19.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 20.11M shares derived: average of 2 quarters · filed 2019-03-22 | 21.42M shares 10-K · filed 2019-03-22 | |
| 2018-09-30 | 20.67M shares 10-Q · filed 2018-11-13 | 22.04M shares 10-Q · filed 2018-11-13 | ||
| 2017-12-31 | 22.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 22.77M shares derived: average of 2 quarters · filed 2019-03-22 | 22.74M shares 10-K · filed 2019-03-22 | |
| 2017-09-30 | 22.76M shares 10-Q · filed 2018-11-13 | 22.73M shares 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |